Neuren Pharmaceuticals
NEU.AX
#5555
Rank
NZ$1.61 B
Marketcap
$12.59
Share price
0.87%
Change (1 day)
-40.29%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2024: NZ$0.19 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2024 the company made an earning of NZ$0.19 Billion a decrease over its 2023 earnings that were of NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024NZ$0.19 B-18.58%
2023NZ$0.23 B111519.63%
2022NZ$0.21 M-102.22%
2021-NZ$9.51 Million-20.06%
2020-NZ$11.9 Million-6.65%
2019-NZ$12.75 Million-449.8%
2018NZ$3.64 M-213.69%
2017-NZ$3.21 Million-80.94%
2016-NZ$16.81 Million-3.07%
2015-NZ$17.34 Million51.42%
2014-NZ$11.46 Million-32.7%
2013-NZ$17.02 Million87.47%
2012-NZ$9.08 Million10.96%
2011-NZ$8.18 Million-4.11%
2010-NZ$8.53 Million21025.61%
2009-NZ$0.05 Million-99.78%
2008-NZ$18.23 Million1.99%
2007-NZ$17.88 Million33.24%
2006-NZ$13.42 Million31.45%
2005-NZ$10.21 Million37.67%
2004-NZ$7.42 Million4.98%
2003-NZ$7.07 Million36.5%
2002-NZ$5.18 Million